Contribution of BRCA1 and BRCA2 to Familial Ovarian Cancer: A Gynecologic Oncology Group Study

By Reedy M.   Gallion H.   Fowler J.M.   Kryscio R.   Smith S.A.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 255-259

Academic Press

Access to resources Recommend Favorite

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study

By Piek Jurgen   Torrenga Bas   Hermsen Brenda   Verheijen René   Zweemer Ronald   Gille Johan   Kenemans Peter   van Diest Paul   Menko Fred  

Familial Cancer, Vol. 2, Iss. 2, 2003-10 ,pp. : 73-78

Springer Publishing Company

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Germline Mutations of theBRCA1andBRCA2Genes in a Breast and Ovarian Cancer Patient

By Randall T.C.   Bell K.A.   Rebane B.A.   Rubin S.C.   Boyd J.  

Gynecologic Oncology, Vol. 70, Iss. 3, 1998-09 ,pp. : 432-434

Elsevier

Access to resources Recommend Favorite

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

By Beller U.   Halle D.   Catane R.   Kaufman B.   Hornreich G.   Levy-Lahad E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite